SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-141058
Filing Date
2016-12-22
Accepted
2016-12-22 18:01:29
Documents
1
Period of Report
2016-12-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v455667_3.html 3  
1 OWNERSHIP DOCUMENT v455667_3.xml 3 3386
  Complete submission text file 0001144204-16-141058.txt   4767
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 ADAMS STREET APT 6B BROOKLYN NY 11201
Business Address
GRAY WILLIAM GARRETT (Reporting) CIK: 0001692961 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55506 | Film No.: 162067623